Cargando…

Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study

Pathogenesis of autoimmune disorders, including multiple sclerosis (MS), has been linked to an alteration of the resident microbial commensal community and of the interplay between the microbiota and the immune system. Dietary components such as fiber, acting on microbiota composition, could, in pri...

Descripción completa

Detalles Bibliográficos
Autores principales: Saresella, Marina, Mendozzi, Laura, Rossi, Valentina, Mazzali, Franca, Piancone, Federica, LaRosa, Francesca, Marventano, Ivana, Caputo, Domenico, Felis, Giovanna E., Clerici, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661395/
https://www.ncbi.nlm.nih.gov/pubmed/29118761
http://dx.doi.org/10.3389/fimmu.2017.01391
_version_ 1783274474374692864
author Saresella, Marina
Mendozzi, Laura
Rossi, Valentina
Mazzali, Franca
Piancone, Federica
LaRosa, Francesca
Marventano, Ivana
Caputo, Domenico
Felis, Giovanna E.
Clerici, Mario
author_facet Saresella, Marina
Mendozzi, Laura
Rossi, Valentina
Mazzali, Franca
Piancone, Federica
LaRosa, Francesca
Marventano, Ivana
Caputo, Domenico
Felis, Giovanna E.
Clerici, Mario
author_sort Saresella, Marina
collection PubMed
description Pathogenesis of autoimmune disorders, including multiple sclerosis (MS), has been linked to an alteration of the resident microbial commensal community and of the interplay between the microbiota and the immune system. Dietary components such as fiber, acting on microbiota composition, could, in principle, result in immune modulation and, thus, could be used to obtain beneficial outcomes for patients. We verified this hypothesis in a pilot study involving two groups of clinically similar relapsing-remitting (RR) MS patients who had undergone either a high-vegetable/low-protein diet (HV/LP diet group; N = 10) or a “Western Diet” (WD group; N = 10) for at least 12 months. Gut microbiota composition, analyzed by 16 S V4 rRNA gene sequencing and immunological profiles, was examined after a minimum of 12 months of diet. Results showed that, in the HV/LP diet group compared to the WD group: (1) Lachnospiraceae family was significantly more abundant; (2) IL-17-producing T CD4+ lymphocytes (p = 0.04) and PD-1 expressing T CD4+ lymphocytes (p = 0.0004) were significantly decreased; and (3) PD-L1 expressing monocytes (p = 0.009) were significantly increased. In the HV/LP diet group, positive correlations between Lachnospiraceae and both CD14+/IL-10+ and CD14+/TGFβ+monocytes (R(Sp) = 0.707, p = 0.05, and R(Sp) = 0.73, p = 0.04, respectively), as well as between Lachnospiraceae and CD4+/CD25+/FoxP3+ T lymphocytes (R(Sp) = 0.68, p = 0.02) were observed. Evaluation of clinical parameters showed that in the HV/LP diet group alone the relapse rate during the 12 months follow-up period and the Expanded Disability Status Scale score at the end of the study period were significantly reduced. Diet modulates dysbiosis and improves clinical parameters in MS patients by increasing anti-inflammatory circuits. Because Lachnospiraceae favor Treg differentiation as well as TGFβ and IL-10 production this effect could be associated with an increase of these bacteria in the microbiota.
format Online
Article
Text
id pubmed-5661395
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-56613952017-11-08 Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study Saresella, Marina Mendozzi, Laura Rossi, Valentina Mazzali, Franca Piancone, Federica LaRosa, Francesca Marventano, Ivana Caputo, Domenico Felis, Giovanna E. Clerici, Mario Front Immunol Immunology Pathogenesis of autoimmune disorders, including multiple sclerosis (MS), has been linked to an alteration of the resident microbial commensal community and of the interplay between the microbiota and the immune system. Dietary components such as fiber, acting on microbiota composition, could, in principle, result in immune modulation and, thus, could be used to obtain beneficial outcomes for patients. We verified this hypothesis in a pilot study involving two groups of clinically similar relapsing-remitting (RR) MS patients who had undergone either a high-vegetable/low-protein diet (HV/LP diet group; N = 10) or a “Western Diet” (WD group; N = 10) for at least 12 months. Gut microbiota composition, analyzed by 16 S V4 rRNA gene sequencing and immunological profiles, was examined after a minimum of 12 months of diet. Results showed that, in the HV/LP diet group compared to the WD group: (1) Lachnospiraceae family was significantly more abundant; (2) IL-17-producing T CD4+ lymphocytes (p = 0.04) and PD-1 expressing T CD4+ lymphocytes (p = 0.0004) were significantly decreased; and (3) PD-L1 expressing monocytes (p = 0.009) were significantly increased. In the HV/LP diet group, positive correlations between Lachnospiraceae and both CD14+/IL-10+ and CD14+/TGFβ+monocytes (R(Sp) = 0.707, p = 0.05, and R(Sp) = 0.73, p = 0.04, respectively), as well as between Lachnospiraceae and CD4+/CD25+/FoxP3+ T lymphocytes (R(Sp) = 0.68, p = 0.02) were observed. Evaluation of clinical parameters showed that in the HV/LP diet group alone the relapse rate during the 12 months follow-up period and the Expanded Disability Status Scale score at the end of the study period were significantly reduced. Diet modulates dysbiosis and improves clinical parameters in MS patients by increasing anti-inflammatory circuits. Because Lachnospiraceae favor Treg differentiation as well as TGFβ and IL-10 production this effect could be associated with an increase of these bacteria in the microbiota. Frontiers Media S.A. 2017-10-25 /pmc/articles/PMC5661395/ /pubmed/29118761 http://dx.doi.org/10.3389/fimmu.2017.01391 Text en Copyright © 2017 Saresella, Mendozzi, Rossi, Mazzali, Piancone, LaRosa, Marventano, Caputo, Felis and Clerici. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Saresella, Marina
Mendozzi, Laura
Rossi, Valentina
Mazzali, Franca
Piancone, Federica
LaRosa, Francesca
Marventano, Ivana
Caputo, Domenico
Felis, Giovanna E.
Clerici, Mario
Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study
title Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study
title_full Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study
title_fullStr Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study
title_full_unstemmed Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study
title_short Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study
title_sort immunological and clinical effect of diet modulation of the gut microbiome in multiple sclerosis patients: a pilot study
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661395/
https://www.ncbi.nlm.nih.gov/pubmed/29118761
http://dx.doi.org/10.3389/fimmu.2017.01391
work_keys_str_mv AT saresellamarina immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy
AT mendozzilaura immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy
AT rossivalentina immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy
AT mazzalifranca immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy
AT pianconefederica immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy
AT larosafrancesca immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy
AT marventanoivana immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy
AT caputodomenico immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy
AT felisgiovannae immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy
AT clericimario immunologicalandclinicaleffectofdietmodulationofthegutmicrobiomeinmultiplesclerosispatientsapilotstudy